Nav: Home

UK study shows increasing proportion of younger adults with type 2 diabetes, with younger cases having a worse metabolic profile

September 17, 2019

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that the proportion of younger adults being diagnosed with type 2 diabetes (T2D) has increased since the start of the century. The study is by Professor Sanjoy Ketan Paul, Chair in Clinical Epidemiology, Biostatistics & Health Services Research, Department of Medicine, University of Melbourne and Dr Digsu Koye, University of Melbourne, Australia and colleagues.

The changes over time, co-existing conditions (comorbidities) and long-term outcomes in young-onset T2D compared to older people with T2D have not been well studied. In this news study, the authors investigated temporal changes over time in young-onset T2D, risk factor control, comorbidities and the risk of developing atherosclerotic cardiovascular disease (ASCVD) and all-cause mortality separately by age groups at diagnosis.

Using nationally representative UK primary care electronic medical records, 370,854 people diagnosed with T2D from January 2000 were identified. The authors extracted data on anthropometric (physical measurements), clinical and laboratory measures and comorbidities (co-existing conditions) at diagnosis of T2D, and ASCVD and all-cause mortality during a median of seven years follow-up. The changes over time (temporal trend) in the proportion of people at diagnosis in the age groups 18-40, 41-50, 51-60, 61-70 and 71-80 were evaluated from 2000 to 2017. The temporal trend of rate / 1000 person years for ASCVD and all-cause mortality were calculated.

Of the 370,854 incident cases of T2DM identified, the mean age was 53 years, and 11% and 16% were in the 18-40 and 41-50 years age groups respectively. Proportion of people in these age groups marginally increased from 9.5% to 12.5% (18-40 years) and 14% to 17.5% (41-50 years) respectively over the 17 years of the study. Thus, in the UK today, around 1 in 8 new cases of T2D is in someone aged 18-40 years, compared to one in 10 in the year 2000.

The youngest group had significantly higher BMI (mean: 35 kg/m2, 71% obese), high blood glucose level (mean HbA1c: 8.6%; 58% with glycated haemoglobin HbA1c ? 7.5%) and levels of low density lipoprotein (bad) cholesterol (71% with LDL-C ? 100 mg/dL) compared to older people.

Furthermore, in the 18-40 years group about one-third had high blood pressure, 2% had ASCVD and 4% had chronic kidney disease. Almost a quarter 23% were identified as having increased cardiovascular risk without the history of ASCVD. In people in the age group 40-49 years at diagnosis, the mean BMI was 34 kg/m2 with 70% being obese, with 55% of patients with HbA1c of 7.5% or over. In the newly diagnosed patients aged 60-69 years, the mean BMI was down to 32 kg/m2 and 57% were obese, with only 38% with HbA1c over 7.5%. (SEE FULL TABLE LINK BELOW)

Rate of ASCVD was declining in all age groups between 2000 and 2006, followed by a stable and similar pattern for all age groups after 2007. The all-cause mortality rate declined over time by around 20% in those 60-69 years group and by around 30% in those 70-79 years group, but remained unchanged in the 18-59 years age groups. The average time to ASCVD or death was not different between high and low-risk status patients in the youngest people with T2DM.

The authors conclude: "The proportion of young-onset T2DM has increased from 2000 to 2017. Young people with T2DM have a higher cardiovascular risk factor burden. While cardiovascular morbidity and mortality risks have declined substantially over the years for older people with T2DM, they remain unchanged for younger people. Young-onset diabetes has a more aggressive phenotype compared to older-onset diabetes. More intense strategies are required to improve longer term cardiovascular and mortality outcomes in this population."
-end-


Diabetologia

Related Diabetes Articles:

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.